Introduction
Impairment of autonomic cardiac control has been discussed as a possible contributing mechanism for sudden unexpected death in epilepsy (SUDEP). 1, 2 Seizure (2007) 16, 504-508 www.elsevier.com/locate/yseiz KEYWORDS SUDEP; Heart rate variability; Epilepsy; Untreated
Summary
Background: Several studies have reported reduced heart rate variability (HRV) in patients with chronic epilepsy under treatment with antiepileptic drugs. This impairment in cardiac autonomic control might be of relevance in relation to the risk of sudden unexpected death in patients with chronic refractory epilepsy. Little information is, however, available on HRV in untreated patients with newly diagnosed epilepsy. Methods: We used spectral analysis to assess HRV based on 24 h ambulatory EKG recordings in 22 consecutive untreated patients with epilepsy (15 with localizationrelated, 4 with generalized idiopathic and 3 with undetermined epilepsy). The HRV in these patients was compared with 22 age and sex matched healthy controls. Results: When analysing the full 24 h recordings, there were no significant difference between the patients and the controls in any of the analyzed measures of HRV: standard deviation of RR-intervals (P = 0.191), total power (P = 0.170), very low frequency power (P = 0.329), low frequency power (LF) (P = 0.161), high frequency power (HF) (P = 0.186) and the LF/HF ratio (P = 0.472). The results were very similar for daytime and nighttime recordings. Conclusion: Our results suggest that there is no major effect of epilepsy as such on HRV in patients with untreated epilepsy. It should be emphasized that this study assessed newly diagnosed patients and that the results may not be applicable to patients with chronic epilepsy. # 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Autonomic cardiac control can be assessed clinically by analysis of heart rate variability (HRV) based on EKG recordings. 3, 4 HRV is of special interest in the context of SUDEP since a reduced HRV has been shown to predict mortality and more specifically sudden death in other conditions than epilepsy, e.g. congestive heart failure, diabetic neuropathy, after acute myocardial infarction and stroke [5] [6] [7] [8] [9] and is according to preliminary observations possibly also a marker for an increased risk of SUDEP. 10 Several studies have reported reduced HRV in patients with newly diagnosed epilepsy 11 or with chronic epilepsy under treatment with antiepileptic drugs. [12] [13] [14] [15] [16] These studies were, however, not designed to distinguish between the effects of epilepsy as such from those of the ongoing drug treatment.
The contribution of the epilepsy per se to the impaired autonomic cardiac control remains to be evaluated. 17, 18 In particular data on HRV in untreated newly diagnosed epilepsy patients is scarce. To date there is only one published report comparing HRV in untreated epilepsy with normal controls. This study from Turkey reported increased sympathetic control of HRV in highly selected young patients with unspecified generalized tonic-clonic seizures compared with healthy controls, 19 but further studies of more representative and better characterized epilepsy patients are needed. The aim of this study was to investigate HRV in patients with untreated epilepsy and to assess the effect of epilepsy per se.
Patients and methods

Patients
Adult patients with newly diagnosed epilepsy attending the Department of Neurology at the Karolinska Hospital in Stockholm, Sweden, were eligible for inclusion in the study. Only patients without antiepileptic drugs (AEDs) were included. Patients with a history of heart failure, coronary heart disease, diabetes, uraemia or any other known disease that might affect the autonomic nervous system were excluded, as were patients with brain tumours and those for which immediate treatment with AEDs was considered necessary. Patients using medication known to affect the heart rate or blood pressure were excluded.
Controls
For each patient one healthy control subject was selected matched for age and sex. The controls were selected from a bank of previously recorded healthy volunteers.
Methods
The patients with epilepsy and their controls had an ambulatory 24 h digital EKG recording during which they were free to practice their normal daily activities. They were asked to keep a seizure-diary during the recordings.
QRS-complexes were classified by automatic analysis of the digitally recorded EKG signal. The consecutive RR-intervals and the corresponding classification code were exported to an ASCII text file. For the frequency domain analysis 5 min epochs of data were analysed by custom made software. The time series of RR-intervals were re-sampled at a frequency of two samples/s (2 Hz). Gaps in the time series due to non-normal RR-intervals (QRS-labelled by the Aspect System classification as noise or ectopic beats) were filled with values calculated by linear interpolation between the adjacent normal RR-intervals. The computer program checked for misclassified drop beats deviating more than three S.D.s from the mean normal RR-interval of each epoch. Epochs with more than 4% of non-normal RR-intervals were excluded from further analysis. At least 50% of a 24 h recording had to be analyzable for a tape to be included, in accordance with issued guidance. 4 All together a maximum of 288 epochs were thus analyzed per patient, representing both active and resting periods. The frequency domain of the time series of RR-intervals was analyzed with an auto regression method. 20 The mean RR-interval of each time series was subtracted and then detrended by applying linear regression. The power spectrum of the frequency domains was divided into four different frequency bands: total power (TP) 0.0033-0.40 Hz (ms 2 ); very low frequency power (VLF), 0.0033-0.04 Hz (ms 2 ); low frequency power (LF), 0.04-0.15 Hz (ms 2 ); high frequency power (HF), 0.15-0.40 Hz (ms 2 ). From the power, we calculated the LF/HF ratio as an index of the balance between sympathetic and parasympathetic influences on HR. 21 HF reflects respiratory sinus arrhythmia and is mainly related to parasympathetic activity. [21] [22] [23] LF oscillations are associated with baroreflexor control of sympathetic activity 21, 22, 24 but parasympathetic activity might also influence LF. 25 In the time domain, the mean of the standard deviations of all normal RR-intervals for all 5 min segments of a 24 h EKG recording (SDRR) was calculated. All analyses were first made for the full 24 h period. Separate analyses were thereafter made for nighttime (00:00 a.m. to 05:00 a.m.) and daytime (07:30 a.m. to 09:30 p.m.), respectively.
A non-paired t-test was used to compare HRV data between patients and controls. Significance was assumed for P-values < 0.05. Stata 7.0 software was used for data analysis (Stata Corporation, USA).
The study was approved by the institutional review board and all patients and healthy subjects gave their informed consent.
Results
We enrolled 24 consecutive adult patients with newly diagnosed epilepsy. Two patients with concomitant diseases known to affect the autonomic nervous system or a history of cardiac diseases were excluded. In total 22 patients (13 female/9 male) were thus included in the study. Patient characteristics are summarized in Table 1 . The median age was 33 years , and the median time from their first seizure to enrolment in the study 27 months (2 days to 20 years). Fifteen of the patients had localization-related, four generalized idiopathic and three undetermined epilepsy.
Twenty-two patients with newly diagnosed epilepsy, without AED, and 22 healthy controls were thus examined. All patients had been seizure free at least 24 h before the EKG recording and none reported seizures during the recording. There was no significant difference in any of the HRV measures between the patients and their controls whether the whole 24 h registration periods were compared or nighttime and daytime recordings were analyzed separately ( Table 2 ). 
Discussion
In this study on 22 patients with untreated epilepsy we could not demonstrate any statistically significant difference in any of the analysed parameters, SDRR, TP, VLF, LF, HF or LF/HF compared to age and sex matched healthy controls. We cannot exclude that the lack of significance was due to the small number of patients and limited statistical power (52% power for a difference in LF with a P < 0.05 level). It is also possible that the broad range of epilepsy and the heterogeneity of seizure types may have affected our results. However, our patients reflect the normal spectrum of patients with adult epilepsy and they were well classified using seizure-semiology, EEG and neuroradiology.
A Turkish study has recently reported reduced HF, increased LF and consequently an increased LF/HF ratio in 42 young men (military recruits) with newly diagnosed generalized tonic-clonic seizures compared with healthy controls. 19 These patients, however, cannot be considered representative of new onset epilepsy in general. The mean frequency of generalized tonic-clonic seizures among these patients was 8 attacks/year for an average of 5.6 years before diagnosis. Consequently, they had suffered a high number of major seizures before they were included in the study. Furthermore, the study failed to classify the type of seizures, partial or generalized, and epilepsy, partly since the patients were not subjected to an EEG examination.
In our present study, we could not confirm the findings from the study of Evrengul et al. 19 In contrast, HRV measures in our patients with newly diagnosed epilepsy were not different in any respect from the results obtained in the age and sex matched healthy controls but the trends in our study suggests lower LF and LF/HF ratio rather than the opposite as in the study of Evrengul et al. 19 . In addition to dissimilarities in patient selection and characterization, there are methodological differences that can contribute to the divergent outcomes of the two studies. In order to qualify for inclusion in the Turkish study, patients had to stay in hospital until they had a seizure recorded on a video-surveillance in the hospital department. The patients had thus been hospitalized for 42 AE 11 (mean AE S.D.) days before the EKG recordings. Although it seems unlikely, it is unclear if the controls had been subjected to the same procedure. In our study, the procedures for assessment of HRV were the same for patients and controls, an ambulatory 24 h EKG recording.
In conclusion, we could not demonstrate any significant difference in HRV measures between our patients with untreated newly diagnosed epilepsy and matched healthy controls. This observation needs to be interpreted with some caution because of the limited number of included patients and the non-significant apparent trend towards lower HRV measures among the patients (Table 2) . Our results, however, suggest that there is no major effect of the epilepsy as such on HRV in patients with newly diagnosed epilepsy. It should be emphasized that this study assessed newly diagnosed patients and that the results may not be applicable to patients with chronic epilepsy. Further studies are needed to assess the effect of epilepsy per se in patients with untreated epilepsy; such a study should be performed on larger patient groups in patients with well classified epilepsy with age and sex matched healthy controls.
